Showing results (31-40 of 170) with videos related to
Sort By:
Pageof 17
Scientific Reports|January 5, 2024
Tuning of liver circadian transcriptome rhythms by thyroid hormone state in male miceLeonardo Vinicius Monteiro de Assis, Lisbeth Harder, José Thalles Lacerda, et al.Elife|July 27, 2022
Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementationLeonardo Vinicius Monteiro de Assis, Lisbeth Harder, José Thalles Lacerda, et al.Deutsches Arzteblatt International|October 24, 2023
Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid DrugsThomas Herdegen, Ingolf CascorbiMethods in Molecular Biology (Clifton, N.J.)|December 2, 2009
Pharmacogenetics of ATP-binding cassette transporters and clinical implicationsIngolf Cascorbi, Sierk HaenischFrontiers in Pharmacology|November 8, 2016
Pharmacogenetics and Predictive Testing of Drug Hypersensitivity ReactionsRuwen Böhm, Ingolf CascorbiExpert Opinion on Pharmacotherapy|January 29, 2008
Pharmacogenomics in acute coronary syndromeCornelia Remmler, Ingolf CascorbiExpert Opinion on Drug Metabolism & Toxicology|August 28, 2014
Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevanceOliver Bruhn, Ingolf CascorbiExpert Opinion on Drug Metabolism & Toxicology|January 18, 2021
ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?Henrike Bruckmueller, Ingolf CascorbiExpert Opinion on Drug Metabolism & Toxicology|May 29, 2024
Understanding the impact of ABCG2 polymorphisms on drug pharmacokinetics: focus on rosuvastatin and allopurinolAnne Kasten, Ingolf CascorbiPageof 17